Seeking Alpha: First-in-Human Clinical Results for SonoVascular's SonoThrombectomy™ System Presented at the 2025 Annual Meeting of the American Venous Forum
First-in-Human Clinical Results for SonoVascular's SonoThrombectomy™ System Presented at the 2025 Annual Meeting of the American Venous Forum
Lexington Herald Leader: Topline Efficacy Data from the enVVeno Medical VenoValve(R) Pivotal Trial to be Presented at the VENOUS2024 American Venous Forum Annual Meeting on
Topline Efficacy Data from the enVVeno Medical VenoValve(R) Pivotal Trial to be Presented at the VENOUS2024 American Venous Forum Annual Meeting on
Sacramento Bee: Positive Topline Efficacy Data Showing Significant Clinical Improvement from enVVeno Medical’s VenoValve(R) Pivotal Trial to be Presented Today at the VENOUS2024 American ...
Positive Topline Efficacy Data Showing Significant Clinical Improvement from enVVeno Medical’s VenoValve(R) Pivotal Trial to be Presented Today at the VENOUS2024 American ...
News Tribune: One-Year Data from the VenoValve(R) U.S. Pivotal Trial Highlighting Impact on Patients’ Quality of Life (QOL) to be Presented Today at the 37th Annual Meeting of the American ...
One-year follow-up data demonstrates sustained improvements across venous specific quality-of-life (QoL) indicators. PMA application for the VenoValve submitted in November 2024, with an FDA decision ...
One-Year Data from the VenoValve(R) U.S. Pivotal Trial Highlighting Impact on Patients’ Quality of Life (QOL) to be Presented Today at the 37th Annual Meeting of the American ...
CHAPEL HILL, N.C., /PRNewswire/ -- SonoVascular, Inc., a clinical stage medical device company focused on bringing to market its SonoThrombectomy ™ System for venous thromboembolism ...
Dr. Ozsvath discusses leadership in venous societies, community engagement in vascular care, venous research priorities, and more.